Cargando…
Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital
This study evaluated an antibiotic stewardship program (ASP) intervention aimed at reducing inpatient fluoroquinolone (FQ) use and examined its impact on ciprofloxacin susceptibilities of gram-negative bacteria in a large 611-bed community hospital. A two-step ASP intervention was implemented: an el...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455014/ https://www.ncbi.nlm.nih.gov/pubmed/33908291 http://dx.doi.org/10.1177/00368504211011876 |
_version_ | 1785096347567783936 |
---|---|
author | Zeana, Cosmina Palmieri, Frank E. Gupta, Vikas Ye, Gang Lao, Peter Yu, Kalvin Kang, Kyoung-Sil Schiller, Larry Purswani, Murli |
author_facet | Zeana, Cosmina Palmieri, Frank E. Gupta, Vikas Ye, Gang Lao, Peter Yu, Kalvin Kang, Kyoung-Sil Schiller, Larry Purswani, Murli |
author_sort | Zeana, Cosmina |
collection | PubMed |
description | This study evaluated an antibiotic stewardship program (ASP) intervention aimed at reducing inpatient fluoroquinolone (FQ) use and examined its impact on ciprofloxacin susceptibilities of gram-negative bacteria in a large 611-bed community hospital. A two-step ASP intervention was implemented: an electronic medical record algorithm that prompted physicians to re-evaluate FQ use shortly after admission and changed institutional UTI/pneumonia guidelines that recommended options alternate to FQs for first-line empiric antibiotic therapy in 2010 and 2011 respectively. Between 2007 and 2017 FQ use and ciprofloxacin susceptibilities of all non-duplicate cultured isolates of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa obtained ≥72 h after admission were reviewed. Ambulatory care isolates served as a comparison group. FQ utilization rates and relationships to ciprofloxacin susceptibility were evaluated using interrupted time series models. Over the 11-year period, FQ use decreased from 110.0 (2007) to 26.2 (2017) days of therapy/1000 days at risk (p < 0.001). Compared to pre-intervention, the estimated (post-intervention) reduction in FQ utilization was 28.4 (95% CI: 10.9–46) days of therapy/1000 days at risk. Reduced FQ utilization was correlated with increase susceptibilities to ciprofloxacin of hospital onset isolates of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis (p < 0.02), and Pseudomonas aeruginosa (p = 0.07). No significant susceptibility change was observed in the ambulatory care isolates. Persuasive interventions by an ASP successfully modified physicians’ inpatient empiric antibiotic use, produced a sustained reduction in FQ utilization rates and increased ciprofloxacin susceptibility to four commonly encountered gram-negative bacteria in a community hospital. |
format | Online Article Text |
id | pubmed-10455014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-104550142023-08-26 Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital Zeana, Cosmina Palmieri, Frank E. Gupta, Vikas Ye, Gang Lao, Peter Yu, Kalvin Kang, Kyoung-Sil Schiller, Larry Purswani, Murli Sci Prog Short Reports This study evaluated an antibiotic stewardship program (ASP) intervention aimed at reducing inpatient fluoroquinolone (FQ) use and examined its impact on ciprofloxacin susceptibilities of gram-negative bacteria in a large 611-bed community hospital. A two-step ASP intervention was implemented: an electronic medical record algorithm that prompted physicians to re-evaluate FQ use shortly after admission and changed institutional UTI/pneumonia guidelines that recommended options alternate to FQs for first-line empiric antibiotic therapy in 2010 and 2011 respectively. Between 2007 and 2017 FQ use and ciprofloxacin susceptibilities of all non-duplicate cultured isolates of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa obtained ≥72 h after admission were reviewed. Ambulatory care isolates served as a comparison group. FQ utilization rates and relationships to ciprofloxacin susceptibility were evaluated using interrupted time series models. Over the 11-year period, FQ use decreased from 110.0 (2007) to 26.2 (2017) days of therapy/1000 days at risk (p < 0.001). Compared to pre-intervention, the estimated (post-intervention) reduction in FQ utilization was 28.4 (95% CI: 10.9–46) days of therapy/1000 days at risk. Reduced FQ utilization was correlated with increase susceptibilities to ciprofloxacin of hospital onset isolates of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis (p < 0.02), and Pseudomonas aeruginosa (p = 0.07). No significant susceptibility change was observed in the ambulatory care isolates. Persuasive interventions by an ASP successfully modified physicians’ inpatient empiric antibiotic use, produced a sustained reduction in FQ utilization rates and increased ciprofloxacin susceptibility to four commonly encountered gram-negative bacteria in a community hospital. SAGE Publications 2021-04-28 /pmc/articles/PMC10455014/ /pubmed/33908291 http://dx.doi.org/10.1177/00368504211011876 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Short Reports Zeana, Cosmina Palmieri, Frank E. Gupta, Vikas Ye, Gang Lao, Peter Yu, Kalvin Kang, Kyoung-Sil Schiller, Larry Purswani, Murli Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital |
title | Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital |
title_full | Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital |
title_fullStr | Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital |
title_full_unstemmed | Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital |
title_short | Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital |
title_sort | association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: results from an 8-year intervention by an antibiotic stewardship program in an inner-city united states hospital |
topic | Short Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455014/ https://www.ncbi.nlm.nih.gov/pubmed/33908291 http://dx.doi.org/10.1177/00368504211011876 |
work_keys_str_mv | AT zeanacosmina associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital AT palmierifranke associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital AT guptavikas associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital AT yegang associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital AT laopeter associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital AT yukalvin associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital AT kangkyoungsil associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital AT schillerlarry associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital AT purswanimurli associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital |